HCA Healthcare, Inc. (HCA) Downgraded to Equal-Weight by Barclays

Market Context

HCA Healthcare, Inc. operates in the Healthcare sector. The stock currently trades at $410.61 with a market capitalization of $117.1B. The stock has declined 10.6% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Barclays's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for HCA Healthcare, Inc.

Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 08, 2026	Barclays	Equal-Weight	N/A
Jul 07, 2026	Cantor Fitzgerald	Overweight	N/A
Jun 22, 2026	TD Cowen	Buy	N/A
Jun 04, 2026	Bernstein	Market Perform	N/A
Apr 27, 2026	RBC Capital	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View HCA Stock Page